Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-02-22 @ 7:04 AM
Study NCT ID:
NCT06920004
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2025-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Sponsor:
argenx
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ARGX-117-2401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None